Prospective study of oral contraceptives and hypertension among women in the United States

Circulation

Volumn 94, Issue 3, 1996, Pages 483-489

  Chasan Taber, Lisa ^a   Willett, Walter C ^a,b   Manson, JoAnn E ^a,b   Spiegelman, Donna ^a   Hunter, David J ^a,b   Curhan, Gary ^a,b   Colditz, Graham A ^a,b   Stampfer, Meir J ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

contraceptives, oral; hypertension

Indexed keywords

ESTROGEN; ETYNODIOL DIACETATE; GESTAGEN; LEVONORGESTREL; NORETHISTERONE; NORETHISTERONE ACETATE; NORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029831866     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.3.483     Document Type: Article

References (24)

1. Weir RJ, Briggs E, Mack A, Naismith L, Taylor L, Wilson E. Blood pressure in women taking oral contraceptives. Br Med J. 1974;1:533-535.
2. Fisch IR, Frank J. Oral contraceptives and blood pressure. JAMA. 1977;237:2499-2503.
3. Meade TW, Haines AP, North WRS, Chakrabarti R, Howarth DJ, Stirling Y. Haemostatic, lipid and blood-pressure profiles of women on oral contraceptives containing 50 μg or 30 μg oestrogen. Lancet. 1977;ii:948-951.
4. Wilson ESB, Cruickshank J, McMaster M, Weir RJ. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen. Br J Obstet Gynaecol. 1984;91:1254-1260.
5. Weir RJ. Effect on blood pressure of changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension. Scott Med J. 1982;27:212-215.
6. Bloch B. The effect of cyclical administration of levonorgestrel and ethinyloestradiol on blood pressure, body mass, blood glucose and serum triglycerides. S Afr Med J. 1979;56:568-570.
7. Khaw K-T, Peart WS. Blood pressure and contraceptive use. Br Med J. 1982;285:403-407.
8. Royal College of General Practitioners. Oral Contraceptives and Health. London, England: Pitman Medical Publishing Co Ltd; 1974.
9. Briggs M, Briggs M. Oestrogen content of oral contraceptives. Lancet. 1977;ii:1233. Letter.
10. Russell-Briefel R, Ezzati T, Perlman J. Prevalence and trends in oral contraceptive use in premenopausal females ages 12-54 years, United States, 1971-1980. Am J Public Health. 1985;75:1173-1176.
11. Dorflinger LJ. Relative potency of progestins used in oral contraceptives. Contraception. 1985;31:557-570.
12. American Medical Association. AMA Drug Evaluations. 5th ed. Chicago, Ill: American Medical Assn; 1983:965-967.
13. American Medical Association. Drug Evaluations Annual 1991. Milwaukee, Wis: American Medical Assn; 1991:982-986.
14. Dickey RP. Managing Contraceptive Pill Patients. Minneapolis, Minn: Creative Informatics; 1987:206-211.
15. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, Hennekens CH, Speizer FE. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123:894-900.
16. Wolf AM, Hunter D, Colditz GA, Manson JE, Stampfer MJ, Corsano KH, Rosner B, Kriska A, Willett WC. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol. 1994;23:991-999.
17. D'Agostino RB, Lee MLT, Belanger AJ, Cupples LA, Andersen K, Kannel WB. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med. 1990;9;1501-1515.
18. Miettinen O. Estimability and estimation in case referent studies. Am J Epidemiol. 1976;103:226-235.
19. Miettinen OS, Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol. 1974;99:325-332.
20. Rosner B, Polk BF. Predictive value of routine blood pressure measurements in screening for hypertension. Am J Epidemiol. 1983; 117:429-442.
21. Woods JW. Oral contraceptives and hypertension. Hypertension. 1988:11(suppl II):II-11-II-15.
22. Blumenstein BA, Douglas MB, Hall WD. Blood pressure changes and oral contraceptive use: a study of 2676 black women in the south-eastern United States. Am J Epidemiol. 1980;112:539-552.
23. Gaspard UJ, Deville JL, DuBois MH. Clinical experience with tri-phasic oral contraceptives (Trigynon) in six hundred cycles. In: Haspels AA, Rolland R, eds. Benefits and Risks of Hormonal Contraception: The Proceedings of an International Symposium. Amsterdam, Netherlands: MTP Press;1982:61-77.
24. Zador G. Clinical performance of a triphasic administration of ethinyl oestradiol and levonorgestrel in comparison with the 30+150 μg fixed dose regimen. In: Haspels AA, Rolland R, eds. Benefits and Risks of Hormonal Contraception: The Proceedings of an International Symposium. Amsterdam, Netherlands: MTP Press; 1982:43-55.